Uptake and intracellular fate of cholera toxin subunit b-modified mesoporous silica nanoparticle-supported lipid bilayers (aka protocells) in motoneurons. 2018

Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, United States.

Cholera toxin B (CTB) modified mesoporous silica nanoparticle supported lipid bilayers (CTB-protocells) are a promising, customizable approach for targeting therapeutic cargo to motoneurons. In the present study, the endocytic mechanism and intracellular fate of CTB-protocells in motoneurons were examined to provide information for the development of therapeutic application and cargo delivery. Pharmacological inhibitors elucidated CTB-protocells endocytosis to be dependent on the integrity of lipid rafts and macropinocytosis. Using immunofluorescence techniques, live confocal and transmission electron microscopy, CTB-protocells were primarily found in the cytosol, membrane lipid domains and Golgi. There was no difference in the amount of motoneuron activity dependent uptake of CTB-protocells in neuromuscular junctions, consistent with clathrin activation at the axon terminals during low frequency activity. In conclusion, CTB-protocells uptake is mediated principally by lipid rafts and macropinocytosis. Once internalized, CTB-protocells escape lysosomal degradation, and engage biological pathways that are not readily accessible by untargeted delivery methods.

UI MeSH Term Description Entries
D008051 Lipid Bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. Bilayers, Lipid,Bilayer, Lipid,Lipid Bilayer
D008297 Male Males
D009046 Motor Neurons Neurons which activate MUSCLE CELLS. Neurons, Motor,Alpha Motorneurons,Motoneurons,Motor Neurons, Alpha,Neurons, Alpha Motor,Alpha Motor Neuron,Alpha Motor Neurons,Alpha Motorneuron,Motoneuron,Motor Neuron,Motor Neuron, Alpha,Motorneuron, Alpha,Motorneurons, Alpha,Neuron, Alpha Motor,Neuron, Motor
D002772 Cholera Toxin An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells. Cholera Toxin A,Cholera Toxin B,Cholera Toxin Protomer A,Cholera Toxin Protomer B,Cholera Toxin Subunit A,Cholera Toxin Subunit B,Choleragen,Choleragenoid,Cholera Enterotoxin CT,Cholera Exotoxin,Cholera Toxin A Subunit,Cholera Toxin B Subunit,Procholeragenoid,Enterotoxin CT, Cholera,Exotoxin, Cholera,Toxin A, Cholera,Toxin B, Cholera,Toxin, Cholera
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012822 Silicon Dioxide Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid. Silica,Aerosil,Aerosil 380,Cristobalite,Quso G-32,Quso G32,Tridymite,380, Aerosil,Dioxide, Silicon,G32, Quso,Quso G 32
D016062 Porosity Condition of having pores or open spaces. This often refers to bones, bone implants, or bone cements, but can refer to the porous state of any solid substance. Porosities

Related Publications

Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
April 2016, Small (Weinheim an der Bergstrasse, Germany),
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
September 2016, ACS nano,
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
May 2012, Advanced healthcare materials,
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
June 2013, Journal of controlled release : official journal of the Controlled Release Society,
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
February 2009, Journal of the American Chemical Society,
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
November 2017, FEBS open bio,
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
February 2016, Journal of materials chemistry. B,
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
March 2012, ACS nano,
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
September 2009, Chemical communications (Cambridge, England),
Maria A Gonzalez Porras, and Paul Durfee, and Sebastian Giambini, and Gary C Sieck, and C Jeffrey Brinker, and Carlos B Mantilla
July 2023, Toxins,
Copied contents to your clipboard!